Form 4 for AXTI AXT INC
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-14 · accession 0001437749-25-035497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-17 | 2025-11-14 | AXTI | YOUNG MORRIS S | CEO | M - OptEx | $5.21 | +70.0K | 2.51M | +3% | +$364.7K |
| D | 2025-11-17 | 2025-11-14 | AXTI | YOUNG MORRIS S | CEO | M - OptEx | $0.00 | -70.0K | 622.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-14 | M | A | 70,000 | $5.21 | 2,509,490 | D | — | — | (F1) Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-11-14 | M | D | 70,000 | $0.00 | 621,953 | D | $5.21 · 2017-10-28 to 2026-10-28 | 70,000 Common Stock | (F2) Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017. |